Jar-Yi Ho

4PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 15, 2026
Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells.

|Aug 13, 2025
Fucoidan Modulates Osteoarthritis Progression Through miR-22/HO-1 Pathway.

Tsung-Hsun Hsieh, Jar-Yi Ho, Chih-Chien Wang

|Feb 25, 2022
Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer.

Cheng-Shuo Huang, Chen-Hua Tsai, Cheng-Ping Yu

|Apr 30, 2021
Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters.

Ying-Si Wu, Jar-Yi Ho, Cheng-Ping Yu

Pageof 1

Frequent Collaborators

3 joint publications

Cheng-Ping Yu

1 joint publications

Chih-Chien Wang

1 joint publications

Yi-Jen Peng

1 joint publications

Ren-Jun Hsu